Previous 10 | Next 10 |
Triterras (TRIT) -17%.SCYNEXIS (SCYX) -18% after initiates equity raise of $50M.ADDvantage Technologies Group (AEY) -13% on Q4 earnings release.Uxin (UXIN) -11% on FQ2 earnings release.Anchiano Therapeutics (ANCN) -11%.Sonnet BioTherapeutics Holdings (SONN)&...
Gainers: Nxt-ID (NXTD) +50%.Diginex (EQOS) +48%.Aethlon Medical (AEMD) +40%.MIND Technology (MIND) +27%.Aclaris Therapeutics (ACRS) +24%.Tilray (TLRY) +23%.MiMedx Group (MDXG) +22%.Amyris (AMRS) +21%.Drive Shack (DS) +20%.Marathon Patent Group (MARA) +19%.Losers: Concord Medical Services...
Gainers: Aethlon Medical (AEMD) +47%. Aclaris Therapeutics (ACRS) +32%. Tilray (TLRY) +23%. MiMedx Group (MDXG) +23%. Sio Gene Therapies (SIOX) +21%.Losers: Concord Medical Services Holdings (CCM) -43%. BioLineRx (BLRX) -30%. vTv Therapeutics (VTVT) -22%. Sensus Healthcare (SRTS) -1...
The first patient has been treated in Aethlon Medical's (AEMD) first-in-human Early Feasibility Study ((EFS)) evaluating the Hemopurifier in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.The EFS study includes 10 to 12 subjects. The primary endpoi...
Aethlon Medical Announces First Patient Treated in First-in-Human Clinical Trial of HEMOPURIFIER® in Head and Neck Cancer SAN DIEGO , Dec. 16, 2020 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device and technology company focuse...
Aethlon Medical (AEMD) appointed Charles J. Fisher, Jr., M.D., as CEO succeeding Dr. Timothy Rodell, effective as of Oct. 30, 2020; served as board chairman since Nov.2017.Mr. Ed Broenniman replaced Dr. Fisher as the chairman, effective as of Oct. 30, 2020."Chuck...
Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer PR Newswire SAN DIEGO, Nov. 3, 2020 SAN DIEGO , Nov. 3, 2020 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing...
Aethlon Medical, Inc. (AEMD) Q2 2020 Earnings Conference Call October 28, 2020 16:30 ET Company Participants James Frakes - Chief Financial Officer & Senior Vice President, Finance Tim Rodell - Chief Executive Officer Charles Fischer - Chairman Conference Call Participants Maura Marie - Z...
Aethlon Medical To Release Second Quarter Financial Results and Host Conference Call on October 28, 2020 PR Newswire SAN DIEGO, Oct. 19, 2020 SAN DIEGO , Oct. 19, 2020 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company f...
Gainers: Staffing 360 Solutions (STAF) +86%.China HGS Real Estate (HGSH) +65%.Huttig Building Products (HBP) +39%.Dragon Victory International (LYL) +35%.SPI Energy (SPI) +30%.Organogenesis (ORGO) +20%.Armata Pharmaceuticals (ARMP) +20%.Cars.com (CARS) +18%.Precigen (PGEN) +17%...
News, Short Squeeze, Breakout and More Instantly...
2024-06-28 12:40:00 ET SAN DIEGO - June 28, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. ( Nasdaq: AEMD ), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal ye...
Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update PR Newswire Conference Call to be Held Today at 4:30 p.m. ET SAN DIEGO , June 27, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Na...
DS Smith Plc. (DITHF) is expected to report for Q4 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Harbour Energy Plc ADR (HBRIY) is expected to report for Q1 2024 Bayerische Motoren Werke AG (BAMXF) is expected to report for Q1 2024 ...